1-아릴옥시메틸-2,4,5-트리플루오로벤젠 유도체의 합성 및 CCL2 발현의 억제 활성
CCL2 overexpression is associated with macrophage recruitment during immune response and poor patientprognosis in various cancers, such as prostate, breast, pancreatic, and liver cancer. For developing CCL2 inhibitors, 1-aryloxymethyl-2,4,5-trifluorobenzene analogs were designed and synthesized by c...
Saved in:
Published in | Yaghag-hoi-ji Vol. 65; no. 5; pp. 370 - 374 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | Korean |
Published |
The Pharmaceutical Society Of Korea
30.10.2021
대한약학회 |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!